Asset Management One’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.8M | Sell |
263,265
-4,259
| -2% | -$357K | 0.06% | 275 |
|
|
2026
Q1 | $21.4M | Sell |
267,524
-1,829
| -0.7% | -$151K | 0.06% | 261 |
|
|
2025
Q4 | $23.4M | Buy |
269,353
+9,604
| +4% | +$788K | 0.07% | 252 |
|
|
2025
Q3 | $20.2M | Buy |
259,749
+7,324
| +3% | +$572K | 0.06% | 282 |
|
|
2025
Q2 | $19.7M | Buy |
252,425
+2,336
| +0.9% | +$174K | 0.06% | 277 |
|
|
2025
Q1 | $18.1M | Buy |
250,089
+8,271
| +3% | +$592K | 0.06% | 290 |
|
|
2024
Q4 | $18.3M | Buy |
241,818
+2,426
| +1% | +$170K | 0.06% | 275 |
|
|
2024
Q3 | $15.8M | Buy |
239,392
+2,188
| +0.9% | +$159K | 0.06% | 318 |
|
|
2024
Q2 | $21.9M | Sell |
237,204
-7,123
| -3% | -$631K | 0.08% | 218 |
|
|
2024
Q1 | $23.3M | Sell |
244,327
-46,075
| -16% | -$3.87M | 0.09% | 216 |
|
|
2023
Q4 | $22.3M | Sell |
290,402
-32,822
| -10% | -$2.28M | 0.09% | 217 |
|
|
2023
Q3 | $22.4M | Buy |
323,224
+1,622
| +0.5% | +$130K | 0.1% | 185 |
|
|
2023
Q2 | $30.3M | Buy |
321,602
+14,236
| +5% | +$1.24M | 0.13% | 149 |
|
|
2023
Q1 | $25.4M | Buy |
307,366
+15,512
| +5% | +$1.22M | 0.12% | 175 |
|
|
2022
Q4 | $21.9M | Sell |
291,854
-16,522
| -5% | -$1.27M | 0.11% | 198 |
|
|
2022
Q3 | $25.5M | Sell |
308,376
-492
| -0.2% | -$47.3K | 0.13% | 161 |
|
|
2022
Q2 | $29.4M | Sell |
308,868
-4,262
| -1% | -$441K | 0.14% | 148 |
|
|
2022
Q1 | $36.9M | Sell |
313,130
-28,177
| -8% | -$3.16M | 0.14% | 144 |
|
|
2021
Q4 | $44.6M | Buy |
341,307
+12,602
| +4% | +$1.47M | 0.16% | 126 |
|
|
2021
Q3 | $37.2M | Buy |
328,705
+625
| +0.2% | +$71.3K | 0.14% | 146 |
|
|
2021
Q2 | $34M | Sell |
328,080
-60,185
| -16% | -$5.67M | 0.13% | 164 |
|
|
2021
Q1 | $32.5M | Sell |
388,265
-18,470
| -5% | -$1.56M | 0.13% | 160 |
|
|
2020
Q4 | $36.6M | Buy |
406,735
+26,250
| +7% | +$2.18M | 0.15% | 140 |
|
|
2020
Q3 | $30.4M | Buy |
380,485
+5,131
| +1% | +$400K | 0.14% | 148 |
|
|
2020
Q2 | $25.9M | Sell |
375,354
-47,358
| -11% | -$3.37M | 0.13% | 168 |
|
|
2020
Q1 | $26.6M | Buy |
422,712
+22,200
| +6% | +$1.6M | 0.16% | 139 |
|
|
2019
Q4 | $31.1M | Sell |
400,512
-12,222
| -3% | -$954K | 0.14% | 155 |
|
|
2019
Q3 | $30.3M | Buy |
412,734
+14,130
| +4% | +$993K | 0.15% | 151 |
|
|
2019
Q2 | $24.5M | Buy |
398,604
+58,608
| +17% | +$3.54M | 0.12% | 182 |
|
|
2019
Q1 | $21.7M | Sell |
339,996
-736,917
| -68% | -$42.1M | 0.12% | 181 |
|
|
2018
Q4 | $54.9M | Buy |
1,076,913
+3,981
| +0.4% | +$201K | 0.13% | 177 |
|
|
2018
Q3 | $62.2M | Buy |
1,072,932
+19,005
| +2% | +$930K | 0.13% | 178 |
|
|
2018
Q2 | $51.2M | Buy |
1,053,927
+37,464
| +4% | +$1.75M | 0.11% | 203 |
|
|
2018
Q1 | $47.3M | Buy |
1,016,463
+18,387
| +2% | +$798K | 0.11% | 217 |
|
|
2017
Q4 | $37.5M | Buy |
998,076
+2,436
| +0.2% | +$89.4K | 0.08% | 269 |
|
|
2017
Q3 | $36.3M | Buy |
995,640
+6,195
| +0.6% | +$236K | 0.09% | 268 |
|
|
2017
Q2 | $39M | Sell |
989,445
-49,824
| -5% | -$1.82M | 0.1% | 233 |
|
|
2017
Q1 | $32.6M | Sell |
1,039,269
-89,451
| -8% | -$2.8M | 0.09% | 268 |
|
|
2016
Q4 | $35.3M | Buy |
1,128,720
+1,029,576
| +1,038% | +$33.4M | 0.09% | 254 |
|
|
2016
Q3 | $3.95M | Buy |
99,144
+441
| +0.4% | +$16.6K | 0.06% | 384 |
|
|
2016
Q2 | $3.21M | Buy |
98,703
+14,070
| +17% | +$481K | 0.05% | 445 |
|
|
2016
Q1 | $2.5M | Buy |
84,633
+135
| +0.2% | +$3.73K | 0.04% | 537 |
|
|
2015
Q4 | $2.24M | Sell |
84,498
-1,986
| -2% | -$51.6K | 0.03% | 559 |
|
|
2015
Q3 | $2M | Buy |
86,484
+7,050
| +9% | +$170K | 0.03% | 621 |
|
|
2015
Q2 | $1.88M | Sell |
79,434
-21,186
| -21% | -$478K | 0.03% | 674 |
|
|
2015
Q1 | $2.4M | Sell |
100,620
-1,428
| -1% | -$32K | 0.03% | 638 |
|
|
2014
Q4 | $2.19M | Buy |
102,048
+1,398
| +1% | +$28.1K | 0.03% | 662 |
|
|
2014
Q3 | $1.72M | Buy |
100,650
+24,126
| +32% | +$381K | 0.02% | 657 |
|
|
2014
Q2 | $1.12M | Sell |
76,524
-5,790
| -7% | -$78.5K | 0.02% | 729 |
|
|
2014
Q1 | $981K | Hold |
82,314
| – | – | 0.02% | 734 |
|
|
2013
Q4 | $905K | Sell |
82,314
-498
| -0.6% | -$5.61K | 0.01% | 773 |
|
|
2013
Q3 | $950K | Buy |
82,812
+9,378
| +13% | +$110K | 0.01% | 759 |
|
|
2013
Q2 | $817K | Buy |
+73,434
| New | +$869K | 0.01% | 738 |
|
Other funds holding EW
Asset Management One's EW Position: Q2 2026 in Review
Asset Management One reduced its Edwards Lifesciences (EW) stake by 1.6% in Q2 2026, selling an estimated $357K and leaving 263,265 shares worth $23.8M. The position accounts for 0.06% of the portfolio, ranked #275.
Asset Management One first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $62.2M in Q3 2018. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Asset Management One held 263,265 shares of Edwards Lifesciences worth $23.8M as of Q2 2026.
- Asset Management One sold 4,259 Edwards Lifesciences shares in Q2 2026, an estimated $357K.
- Edwards Lifesciences made up 0.06% of Asset Management One's portfolio in Q2 2026, its #275 holding.
- Asset Management One first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Asset Management One's Edwards Lifesciences position peaked at $62.2M in Q3 2018.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.